Willkommen bei Valicare!
-
GMP-Beratung und -Compliance ist eine unserer Stärken. Ob GAP-Analysen, Konzeptionierung, Aktualisierung oder Implementierung eines GMP-Systems unsere GMP-Experten unterstützen Sie kompetent und effizient.
Mehr erfahren -
Besuchen Sie unseren Stand Nr.3 auf den Deutschen Biotechnologietagen vom 20-21.09.2021 in Stuttgart.
Mehr erfahren
Events
Nachrichten aus aller Welt
Unser internationaler Pressespiegel zeigt eine Auswahl an Nachrichten und neusten Artikel zu den Themen Arzneimittel neuartiger Therapien (ATMP), Chimäre Antigenrezeptor(CAR)-T-Zell-Therapie, Tumor infiltrierende Lymphozyten (TIL) und biotechnologisch bearbeitete Gewebeprodukte (TEP).
The use of adipose tissue and its derivates to stimulate and support wound healing processes - An updated review
10.09.2021 | Science DirectHighlights • The cost of isolation, purification, and population of adipose derived stem cells limits their widespread use. • The benefit ...
Gewebekultur im All
10.09.2021 | Medizin & Technik
Filamentous Bacteriophage—A Powerful Carrier for Glioma Therapy
10.09.2021 | FrontiersGlioma is a life-threatening malignant tumor. Resistance to traditional treatments and tumor recurrence present major challenges in ...
Elevating Patient Care with Additive Manufacturing
10.09.2021 | Manufacturing EngineeringThe field of health care is often considered to be one of the most dynamic. The speed at which innovation is occurring—from the way ...
Pfizer and BioNTech submit a variation to EMA with the data in support of a booster dose of COMIRNATY®
09.09.2021 | World Pharma News
Where AI and Immunotherapy Converge to Reprogram Immunity
09.09.2021 | Bio SpacePublished: Sep 09, 2021 By Heather McKenzie Immunai Co-founder and CTO Luis Voloch/Courtesy of Immunai. The roles of artificial ...
Targeted Therapies, Immunotherapies Lead the Way to Optimal Benefit in T-ALL
08.09.2021 | Targeted OncologyOver the past 60 years, overall improvements in the cure rate for patients with T-cell acute lymphoblastic leukemia (T-ALL) have been one ...
CDMO Trends: End-to-End Service Providers
08.09.2021 | DCAT Value Chain InsightsWill the trend of combining API and drug-product development and manufacturing services into a “one-stop shop” business model for CDMOs ...
FDA Summit on Gene Therapy Risks Proves Timely
07.09.2021 | Bio SpacePublished: Sep 07, 2021 By Heather McKenzie When the U.S . Food and Drug Administration (FDA) met last week to discuss gene therapy ...
Clinical Relevance of Serum Kyn/Trp Ratio and Basal and IFNγ-Upregulated IDO1 Expression in Peripheral Monocytes in Early Stage Melanoma
07.09.2021 | FrontiersImmune escape is an early phenomenon in cancer development/progression. Indoleamine 2,3-dioxygenase 1 (IDO1) is a normal endogenous ...
Blutgefäß wächst in künstlicher Umgebung
07.09.2021 | Medizin & Technik
Clinical Catch-Up: August 30-September 3
06.09.2021 | Bio SpacePublished: Sep 06, 2021 By Mark Terry There were a fair number of clinical trial announcements last week. Here’s a look. COVID-19- ...
CAR T-Cell Therapy P-PSMA-101 Demonstrates Promising Early Data in mCRPC
03.09.2021 | Cancer NetworkPreliminary findings indicate that P-PSMA-101, a CAR T-cell therapy, may be efficacious in patient with metastatic castration-resistant ...
TREM2: Keeping Pace With Immune Checkpoint Inhibitors in Cancer Immunotherapy
03.09.2021 | FrontiersTo date, immune checkpoint inhibitors have been successively approved and widely used in clinical cancer treatments, however, the overall ...
Targeting Indoleamine 2,3-Dioxygenase 1: Fighting Cancers via Dormancy Regulation
03.09.2021 | FrontiersThe connection between indoleamine 2,3-dioxygenase 1 (IDO1) and tumour dormancy – a quiescent state of tumour cells which has been ...
Valicare – kompetent, zuverlässig & effizient
Sie haben wenig Zeit und möchten trotzdem wissen, welche Dienstleistungen die Valicare GmbH anbietet?